LAC25 Antibody

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology

The term "LAC25" does not align with established antibody nomenclature or gene/protein naming conventions. Potential misinterpretations include:

  • LACTB Antibody (#25498):
    A commercially available antibody targeting mitochondrial serine protease LACTB (Molecular Weight: 54 kDa), validated for Western blotting in human, mouse, rat, and monkey samples .

  • LRRC25 Protein:
    A leucine-rich repeat-containing protein implicated in Alzheimer’s disease (AD) pathogenesis, with increased expression observed in AD patient brains and iPSC-derived neurons .

  • LAC (Lupus Anticoagulant):
    An autoantibody associated with antiphospholipid syndrome (APS), detected via clotting assays .

LACTB Antibody (#25498)

PropertyDescription
TargetLACTB (UniProt: Q6P1A2)
ApplicationsWestern Blot (WB)
ReactivityHuman, Mouse, Rat, Monkey
SourceRabbit polyclonal
Key FindingsDetects endogenous LACTB in mitochondrial lysates .

LRRC25 in Neurological Research

  • Expression: Elevated in astrocytes, microglia, and neurons in AD models (+153% in AD brains vs. controls) .

  • Function: Regulates autophagy and NF-κB signaling, potentially influencing amyloid-β clearance .

  • Therapeutic Implications: May modulate proteasome activity but requires further validation .

Potential Causes for Ambiguity

  • Typographical Errors: "LAC25" may refer to LACTB or LRRC25, both studied in disease models .

  • Commercial Variants: Antibodies like Anti-CLIC5 (#ACL-025) or Anti-SNAP25 are well-documented but unrelated .

  • Therapeutic Antibodies: Over 160 antibody therapeutics are in clinical use, but none named "LAC25" .

Recommendations for Further Research

  1. Verify Target Identity: Cross-check gene symbols (e.g., HGNC, UniProt) for accuracy.

  2. Explore Homologs: Investigate LRRC25 or LACTB pathways if studying neurodegeneration or mitochondrial biology.

  3. Antibody Databases: Query repositories like the Antibody Society or CiteAb for unpublished/non-commercial antibodies .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
LAC25 antibody; Os12g0259800 antibody; LOC_Os12g15920Laccase-25 antibody; EC 1.10.3.2 antibody; Benzenediol:oxygen oxidoreductase 25 antibody; Diphenol oxidase 25 antibody; Urishiol oxidase 25 antibody
Target Names
LAC25
Uniprot No.

Target Background

Function
**Target Function:** Lignin degradation and detoxification of lignin-derived products.
Database Links
Protein Families
Multicopper oxidase family
Subcellular Location
Secreted, extracellular space, apoplast.

Q&A

What is the LM25 antibody and what specific epitopes does it recognize?

LM25 is a rat IgM monoclonal antibody generated using a neoglycoprotein incorporating the xylosylated/galactosylated oligosaccharides from tamarind xyloglucan (specifically XXLG & XLLG motifs). This antibody recognizes a range of xyloglucan-specific oligosaccharide motifs across multiple plant species. The epitope specificity is primarily directed toward xylosyl/galactosyl residues within the xyloglucan structure. This makes LM25 particularly valuable for researchers studying xyloglucan distribution in plant cell walls, as it binds to this hemicellulose which plays a crucial role in primary cell wall architecture .

What is the significance of xyloglucan in plant cell wall research?

Xyloglucan is a hemicellulose polysaccharide found in the primary cell wall of all vascular plants. Its structural significance stems from its ability to bind to the surface of cellulose microfibrils and potentially link them together, forming a crucial part of the load-bearing network in growing cell walls. When designing experiments to study cell wall architecture, researchers should consider that xyloglucan contributes to wall extensibility and strength during plant development. The LM25 antibody provides a specific tool for visualizing and quantifying this important structural component across different tissues and developmental stages .

What are the recommended storage conditions and handling procedures for optimal LM25 antibody performance?

For optimal performance of the LM25 antibody, storage conditions should be carefully maintained: +4°C for short-term storage (up to 1 month) and -20°C for long-term storage. The antibody is shipped at ambient temperature in cell culture supernatant containing 0.05% sodium azide as a preservative. To maintain antibody activity, researchers should avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt. When designing experimental workflows, plan for proper antibody handling to prevent degradation - thaw aliquots on ice, centrifuge briefly before use to remove any precipitates, and return to appropriate storage immediately after use .

What established applications has LM25 been validated for, and at what dilutions?

The LM25 antibody has been validated for immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA) applications. For both applications, the recommended working dilution is 1:10 from the supplied cell culture supernatant. This dilution has been optimized to provide sufficient signal while minimizing background. When designing experiments with LM25, researchers should include appropriate controls, such as sections from xyloglucan-deficient tissues or pre-absorption of the antibody with purified xyloglucan, to validate specificity of binding patterns .

How can the LM25 antibody be utilized in comparative studies of cell wall composition across diverse plant species?

When designing comparative studies across plant species, researchers should consider that while LM25 recognizes xyloglucan in all land plants, the fine structure and abundance of xyloglucan can vary significantly between species. For robust experimental design:

  • Include phylogenetically diverse plant samples to map evolutionary patterns of xyloglucan structure

  • Use consistent tissue types and developmental stages for valid comparisons

  • Employ quantitative approaches (such as competitive ELISA) to assess relative xyloglucan abundance

  • Combine with microscopy to determine spatial distribution differences

For challenging specimens, consider tissue-specific extraction protocols before immunolabeling, as matrix effects can influence antibody accessibility differently across species. Cross-validation with biochemical techniques such as linkage analysis can provide complementary structural information to confirm antibody-based observations .

What methodological considerations should be addressed when using LM25 for high-resolution imaging of xyloglucan distribution?

To achieve optimal high-resolution imaging of xyloglucan distribution using LM25:

  • Sample preparation is critical - fixation protocols should preserve cell wall structure while maintaining epitope accessibility

  • For confocal microscopy, use thin sections (2-5 μm) for optimal signal-to-noise ratio

  • When performing super-resolution microscopy:

    • Consider using secondary antibodies conjugated with bright, photostable fluorophores

    • Adjust antibody concentration (starting with 1:10 and titrating as needed)

    • Include appropriate mounting media to reduce photobleaching

When analyzing complex tissues, sequential enzymatic digestion with specific cell wall-degrading enzymes before immunolabeling can reveal masked epitopes. For co-localization studies with other cell wall components, careful selection of compatible primary antibodies from different host species is essential to avoid cross-reactivity .

How can LM25 be integrated into studies examining cell wall remodeling during plant development and stress responses?

For investigating dynamic cell wall remodeling processes:

  • Design time-course experiments capturing key developmental transitions or stress exposure periods

  • Combine LM25 immunolabeling with complementary techniques to assess:

    • Gene expression of xyloglucan-related enzymes (XTHs, expansins)

    • Mechanical properties of cell walls using atomic force microscopy

    • Metabolic labeling of newly synthesized xyloglucan

When analyzing stress responses, consider that accessibility of xyloglucan epitopes may change due to cross-linking with other polymers or conformational changes. This requires careful interpretation of altered labeling patterns - decreased labeling may indicate either reduced xyloglucan content or epitope masking. Complementary approaches such as biochemical fractionation followed by immunodot assays can help distinguish between these possibilities .

What is the recommended protocol for immunofluorescence labeling of plant tissues using LM25?

Optimized Immunofluorescence Protocol for Plant Tissues:

  • Sample Preparation:

    • Fix fresh tissue in 4% paraformaldehyde in PBS for 1-2 hours

    • Dehydrate through ethanol series (30%, 50%, 70%, 90%, 100%)

    • Embed in appropriate medium (paraffin or resin)

    • Section at 4-5 μm thickness

  • Immunolabeling:

    • Deparaffinize and rehydrate sections

    • Block with 3% BSA in PBS for 30 minutes

    • Apply LM25 antibody (1:10 dilution) and incubate for 2 hours at room temperature

    • Wash 3x with PBS

    • Apply appropriate secondary antibody (anti-rat IgM) conjugated to desired fluorophore

    • Counterstain cell walls if needed (Calcofluor White for cellulose)

    • Mount in anti-fade medium

For enhanced sensitivity in tissues with low xyloglucan content, consider using a biotin-streptavidin amplification system. When optimizing this protocol for specific plant species or tissues, systematic modification of fixation times and blocking agents may be necessary to achieve optimal signal-to-noise ratio .

What approaches can resolve inconsistent LM25 labeling patterns in recalcitrant plant tissues?

When encountering inconsistent labeling patterns in challenging tissues:

  • Epitope Masking Issues:

    • Implement enzymatic pretreatments (pectinase, xylanase) to remove potentially masking polymers

    • Test different fixation protocols (aldehyde-based vs. alcohol-based)

    • Evaluate the effect of different antigen retrieval methods:
      a. Heat-induced (microwave treatment in citrate buffer)
      b. Enzymatic (proteinase K)

  • Penetration Issues:

    • For lignified tissues, include delignification steps (sodium chlorite)

    • Increase incubation times and use detergent (0.1% Triton X-100) in antibody solutions

    • Consider vacuum infiltration of antibody solutions

  • Background Reduction:

    • Test different blocking agents (milk powder, serum, glycine)

    • Increase washing stringency (duration, salt concentration)

    • Pre-absorb secondary antibodies with plant tissue powder

Systematic troubleshooting through a matrix of these variables can identify optimal conditions for specific research materials .

How can LM25 be effectively used in quantitative ELISA assays for xyloglucan content analysis?

Optimized ELISA Protocol for Xyloglucan Quantification:

  • Sample Preparation:

    • Extract cell wall material using established protocols

    • Solubilize xyloglucan-enriched fractions (1M KOH extraction followed by neutralization)

    • Prepare serial dilutions to ensure measurements within linear range

  • ELISA Procedure:

    • Coat plates with extracted polysaccharides (overnight at 4°C)

    • Block with 3% BSA in PBS (1 hour at room temperature)

    • Incubate with LM25 (1:10 dilution, 2 hours at room temperature)

    • Wash 3x with PBS-T (PBS + 0.1% Tween-20)

    • Apply HRP-conjugated secondary antibody

    • Develop with appropriate substrate and measure absorbance

  • Data Analysis:

    • Generate standard curves using purified tamarind xyloglucan

    • Calculate relative xyloglucan content based on signal intensity

    • Normalize to total cell wall mass or specific cell wall fraction

For competitive ELISA to measure xyloglucan in solution, pre-incubate LM25 with sample before adding to plates coated with standard xyloglucan. Signal reduction corresponds to xyloglucan concentration in the sample .

What complementary techniques should be used alongside LM25 immunolabeling for comprehensive xyloglucan characterization?

For thorough characterization of xyloglucan structure and function:

TechniqueApplicationComplementary Information to LM25 Labeling
MALDI-TOF MSOligosaccharide analysisPrecise structural information on xyloglucan subunits
Size exclusion chromatographyPolymer size distributionMolecular weight profile of xyloglucan populations
Linkage analysis (methylation analysis)Glycosidic linkage determinationDetailed structural information on branching patterns
AFM/micropipette techniquesMechanical propertiesCorrelation between xyloglucan abundance and wall mechanics
Reverse geneticsFunctionPhenotypic effects of altered xyloglucan structure

How does LM25 compare with other xyloglucan-directed antibodies in current research applications?

LM25 offers distinct advantages compared to other xyloglucan antibodies:

  • Epitope Specificity:

    • LM25 recognizes xylosyl/galactosyl residues in xyloglucan

    • This differs from LM15 (recognizes XXXG motif) and LM24 (recognizes XXLG and XLLG motifs with different affinity)

    • The unique epitope recognition profile makes LM25 valuable for detecting distinct xyloglucan subpopulations

  • Comparative Performance:

    • Shows broader species reactivity across land plants than some other xyloglucan antibodies

    • Exhibits complementary labeling patterns to LM15 in some tissues, revealing heterogeneity in xyloglucan structure

When designing experiments requiring xyloglucan visualization, researchers should consider using multiple antibodies with different epitope specificities to obtain a comprehensive view of xyloglucan distribution and structure. This approach can reveal microheterogeneity in xyloglucan composition that might be missed using a single antibody .

What emerging research areas could benefit from LM25 antibody applications?

Several cutting-edge research domains could leverage LM25 for novel insights:

  • Synthetic Biology and Biomaterials:

    • Characterizing engineered xyloglucan structures for customized biomaterials

    • Monitoring incorporation of modified xyloglucans into artificial cell walls

  • Climate Change Adaptation:

    • Studying cell wall remodeling under drought and temperature stress

    • Investigating species-specific differences in xyloglucan modification as adaptive mechanisms

  • Evolutionary Developmental Biology:

    • Mapping xyloglucan distribution across primitive plant lineages

    • Correlating xyloglucan structural diversity with morphological innovations

  • High-throughput Phenotyping:

    • Developing LM25-based screening methods for cell wall mutants

    • Quantitative imaging of xyloglucan patterns in response to environmental variables

As plant cell wall research integrates with systems biology approaches, antibodies like LM25 will become increasingly valuable for connecting molecular-level polymer characteristics with whole-plant phenotypes .

What controls should be included when using LM25 for rigorous experimental validation?

To ensure robust experimental design with LM25:

  • Essential Negative Controls:

    • Primary antibody omission (secondary antibody only)

    • Non-immune rat IgM at equivalent concentration

    • Pre-absorption of LM25 with purified xyloglucan

    • Xyloglucan-deficient mutant tissues (e.g., xxt1/xxt2 Arabidopsis)

  • Positive Controls:

    • Known xyloglucan-rich tissues (e.g., nasturtium seed cotyledons)

    • Pure xyloglucan standards (tamarind xyloglucan)

  • Specificity Validation:

    • Enzymatic pre-treatments with xyloglucanase vs. other cell wall degrading enzymes

    • Competitive inhibition with purified oligosaccharide fragments

  • Technical Validation:

    • Serial dilution of primary antibody to confirm signal proportionality

    • Replicate samples from independent biological specimens

How should researchers interpret conflicting results between LM25 immunolabeling and biochemical xyloglucan analyses?

When facing discrepancies between immunolabeling and biochemical data:

  • Consider Epitope Accessibility Issues:

    • LM25 requires physical access to its epitope, which may be obscured in intact cell walls

    • Negative immunolabeling despite biochemical detection may indicate masking rather than absence

  • Evaluate Extraction Efficiency:

    • Biochemical methods depend on extraction conditions that may not solubilize all xyloglucan populations

    • Different extraction protocols can yield conflicting quantitative results

  • Assess Epitope Abundance vs. Polymer Abundance:

    • LM25 detects specific epitopes that may represent only a subset of total xyloglucan

    • Changes in xyloglucan fine structure can affect antibody binding without changing total content

  • Resolution Strategies:

    • Employ sequential extraction procedures followed by immunodot assays

    • Use enzymatic pre-treatments to unmask epitopes

    • Combine microscopy with in situ enzymatic digestion to confirm specificity

Methodological triangulation using multiple independent techniques provides the most reliable assessment of xyloglucan distribution and abundance .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.